HOUSTON, Sept. 08, 2017 -- Emerson Scott, LLP announces a continuing investigation of the Wells Fargo residential mortgage fee and charges matters. This investigation relates to borrowers at Wells Fargo who were wrongfully charged rate lock extension fees.
If you applied for or refinanced a Wells Fargo residential mortgage and were charged one or more fees to extend a mortgage interest rate lock period or “Rate Lock Extension Fees” then you may have claims that may be pursued. It is believed that Wells Fargo delayed loan approval to wrongfully charge mortgage customers these fees.
Wells Fargo is the nation’s largest home lender and controlled about 12 percent of the country’s 2016 mortgage market. This investigation concerns people who financed or refinanced their homes with Wells Fargo & Company, Wells Fargo Bank, N.A., and Wells Fargo Home Mortgage.
Emerson Scott, LLP, with offices in Houston, TX and Little Rock, AR, is a law firm specializing in results, integrity, and personal service. Emerson Scott, LLP represents consumers throughout the nation and has significant class action experience with proven results. Emerson Scott, LLP lawyers have devoted their practice to complex commercial litigation for more than thirty years and have recovered hundreds of millions of dollars for consumers in class actions throughout the United States.
IMPORTANT: If you believe that you were wrongfully charged “Rate Lock Extension Fees” while Wells Fargo delayed your loan approval then please contact us immediately to protect your rights. It makes no difference what state you reside in. Contact plaintiff’s counsel, Emerson Scott, LLP, at the following numbers: 281-488-8854 or 501-907-2555. Or contact us via e-mail to John G. Emerson ([email protected]) or David G. Scott ([email protected]).


Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



